- 11-50 Employees
- Based in San Carlos, California
BioCardia, Inc., headquartered in San Carlos, California, is developing autologous and allogenic cell-based therapies to treat cardiovascular disease. CardiAMP™ and CardiALLO™ cell therapies are the Company’s biotherapeutic product candidates in clinical development. The Company has also developed a portfolio of approved enabling products that optimize delivery of its cell therapies.
Most Recent Annual Report
2022 Annual Report and Form 10K
Older/Archived Annual Reports